Skip to main content
Top
Published in: Pediatric Nephrology 1/2004

01-01-2004 | Review

Genetics of hereditary disorders of magnesium homeostasis

Authors: Karl P. Schlingmann, Martin Konrad, Hannsjörg W. Seyberth

Published in: Pediatric Nephrology | Issue 1/2004

Login to get access

Abstract

Magnesium plays an essential role in many biochemical and physiological processes. Homeostasis of magnesium is tightly regulated and depends on the balance between intestinal absorption and renal excretion. During the last decades, various hereditary disorders of magnesium handling have been clinically characterized and genetic studies in affected individuals have led to the identification of some molecular components of cellular magnesium transport. In addition to these hereditary forms of magnesium deficiency, recent studies have revealed a high prevalence of latent hypomagnesemia in the general population. This finding is of special interest in view of the association between hypomagnesemia and common chronic diseases such as diabetes, coronary heart disease, hypertension, and asthma. However, valuable methods for the diagnosis of body and tissue magnesium deficiency are still lacking. This review focuses on clinical and genetic aspects of hereditary disorders of magnesium homeostasis. We will review primary defects of epithelial magnesium transport, disorders associated with defects in Ca2+/ Mg2+ sensing, as well as diseases characterized by renal salt wasting and hypokalemic alkalosis, with special emphasis on disturbed magnesium homeostasis.
Literature
1.
go back to reference Cole DE, Quamme GA (2000) Inherited disorders of renal magnesium handling. J Am Soc Nephrol 11:1937–1947PubMed Cole DE, Quamme GA (2000) Inherited disorders of renal magnesium handling. J Am Soc Nephrol 11:1937–1947PubMed
2.
go back to reference Konrad M, Weber S (2003) Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 14:249–260 Konrad M, Weber S (2003) Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 14:249–260
3.
go back to reference Schimatschek HF, Rempis R (2001) Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 14:283–290PubMed Schimatschek HF, Rempis R (2001) Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 14:283–290PubMed
4.
go back to reference Sanders GT, Huijgen HJ, Sanders R (1999) Magnesium in disease: a review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med 37:1011–1033PubMed Sanders GT, Huijgen HJ, Sanders R (1999) Magnesium in disease: a review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med 37:1011–1033PubMed
5.
go back to reference Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A (2000) Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 294:1–26CrossRefPubMed Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A (2000) Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 294:1–26CrossRefPubMed
6.
go back to reference Elin RJ (1994) Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol 102:616–622PubMed Elin RJ (1994) Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol 102:616–622PubMed
7.
go back to reference Avioli LV, Berman M (1966) Mg28 kinetics in man. J Appl Physiol 21:1688–1694 Avioli LV, Berman M (1966) Mg28 kinetics in man. J Appl Physiol 21:1688–1694
8.
go back to reference Seelig MS (1964) The requirement of magnesium by the normal adult. Summary and analysis of. J Am Coll Nutr 14:342–390 Seelig MS (1964) The requirement of magnesium by the normal adult. Summary and analysis of. J Am Coll Nutr 14:342–390
9.
go back to reference EU-SCOF (2001) Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Magnesium. European Commission Health and Consumer Protection Directorate-Generale, Brussels, pp 1–16 EU-SCOF (2001) Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Magnesium. European Commission Health and Consumer Protection Directorate-Generale, Brussels, pp 1–16
10.
go back to reference Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FNB, Institute of Medicine (1999) Magnesium. In: National Academy of Sciences (ed) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academies Press, Washington, D.C., pp 190–249 Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FNB, Institute of Medicine (1999) Magnesium. In: National Academy of Sciences (ed) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academies Press, Washington, D.C., pp 190–249
11.
go back to reference Kerstan D, Quamme G (2002) Physiology and pathophysiology of intestinal absorption of magnesium. In: Massry SG, Morii H, Nishizawa Y (eds) Calcium in internal medicine. Springer-Verlag, London Berlin Heidelberg, pp 171–183 Kerstan D, Quamme G (2002) Physiology and pathophysiology of intestinal absorption of magnesium. In: Massry SG, Morii H, Nishizawa Y (eds) Calcium in internal medicine. Springer-Verlag, London Berlin Heidelberg, pp 171–183
12.
go back to reference Quamme GA, Rouffignac C de (2000) Epithelial magnesium transport and regulation by the kidney. Front Biosci 5:D694–D711PubMed Quamme GA, Rouffignac C de (2000) Epithelial magnesium transport and regulation by the kidney. Front Biosci 5:D694–D711PubMed
13.
go back to reference Fine KD, Santa Ana CA, Porter JL, Fordtran JS (1991) Intestinal absorption of magnesium from food and supplements. J Clin Invest 88:396–402PubMed Fine KD, Santa Ana CA, Porter JL, Fordtran JS (1991) Intestinal absorption of magnesium from food and supplements. J Clin Invest 88:396–402PubMed
14.
go back to reference Rouffignac C de, Quamme G (1994) Renal magnesium handling and its hormonal control. Physiol Rev 74:305–322PubMed Rouffignac C de, Quamme G (1994) Renal magnesium handling and its hormonal control. Physiol Rev 74:305–322PubMed
15.
go back to reference Lelievre-Pegorier M, Merlet-Benichou C, Roinel N, Rouffignac C de (1983) Developmental pattern of water and electrolyte transport in rat superficial nephrons. Am J Physiol 245:F15–F21PubMed Lelievre-Pegorier M, Merlet-Benichou C, Roinel N, Rouffignac C de (1983) Developmental pattern of water and electrolyte transport in rat superficial nephrons. Am J Physiol 245:F15–F21PubMed
16.
go back to reference Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA (2001) Magnesium transport in the renal distal convoluted tubule. Physiol Rev 81:51–84PubMed Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA (2001) Magnesium transport in the renal distal convoluted tubule. Physiol Rev 81:51–84PubMed
17.
go back to reference Quamme GA (1997) Renal magnesium handling: new insights in understanding old problems. Kidney Int 52:1180–1195PubMed Quamme GA (1997) Renal magnesium handling: new insights in understanding old problems. Kidney Int 52:1180–1195PubMed
18.
19.
go back to reference Tsuji H, Venditti FJ Jr, Evans JC, Larson MG, Levy D (1994) The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am J Cardiol 74:232–235PubMed Tsuji H, Venditti FJ Jr, Evans JC, Larson MG, Levy D (1994) The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am J Cardiol 74:232–235PubMed
20.
go back to reference Saha H, Harmoinen A, Karvonen AL, Mustonen J, Pasternack A (1998) Serum ionized versus total magnesium in patients with intestinal or liver disease. Clin Chem Lab Med 36:715–718PubMed Saha H, Harmoinen A, Karvonen AL, Mustonen J, Pasternack A (1998) Serum ionized versus total magnesium in patients with intestinal or liver disease. Clin Chem Lab Med 36:715–718PubMed
21.
go back to reference Hebert P, Mehta N, Wang J, Hindmarsh T, Jones G, Cardinal P (1997) Functional magnesium deficiency in critically ill patients identified using a magnesium-loading test. Crit Care Med 25:749–755PubMed Hebert P, Mehta N, Wang J, Hindmarsh T, Jones G, Cardinal P (1997) Functional magnesium deficiency in critically ill patients identified using a magnesium-loading test. Crit Care Med 25:749–755PubMed
22.
go back to reference Hashimoto Y, Nishimura Y, Maeda H, Yokoyama M (2000) Assessment of magnesium status in patients with bronchial asthma. J Asthma 37:489–496PubMed Hashimoto Y, Nishimura Y, Maeda H, Yokoyama M (2000) Assessment of magnesium status in patients with bronchial asthma. J Asthma 37:489–496PubMed
23.
go back to reference Arnold A, Tovey J, Mangat P, Penny W, Jacobs S (1995) Magnesium deficiency in critically ill patients. Anaesthesia 50:203–205PubMed Arnold A, Tovey J, Mangat P, Penny W, Jacobs S (1995) Magnesium deficiency in critically ill patients. Anaesthesia 50:203–205PubMed
24.
go back to reference Sutton RA, Domrongkitchaiporn S (1993) Abnormal renal magnesium handling. Miner Electrolyte Metab 19:232–240PubMed Sutton RA, Domrongkitchaiporn S (1993) Abnormal renal magnesium handling. Miner Electrolyte Metab 19:232–240PubMed
25.
go back to reference Elisaf M, Panteli K, Theodorou J, Siamopoulos KC (1997) Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia. Magnes Res 10:315–320PubMed Elisaf M, Panteli K, Theodorou J, Siamopoulos KC (1997) Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia. Magnes Res 10:315–320PubMed
26.
go back to reference Tang NL, Cran YK, Hui E, Woo J (2000) Application of urine magnesium/creatinine ratio as an indicator for insufficient magnesium intake. Clin Biochem 33:675–678CrossRefPubMed Tang NL, Cran YK, Hui E, Woo J (2000) Application of urine magnesium/creatinine ratio as an indicator for insufficient magnesium intake. Clin Biochem 33:675–678CrossRefPubMed
27.
go back to reference Nicoll GW, Struthers AD, Fraser CG (1991) Biological variation of urinary magnesium. Clin Chem 37:1794–1795PubMed Nicoll GW, Struthers AD, Fraser CG (1991) Biological variation of urinary magnesium. Clin Chem 37:1794–1795PubMed
28.
go back to reference Djurhuus MS, Gram J, Petersen PH, Klitgaard NA, Bollerslev J, Beck-Nielsen H (1995) Biological variation of serum and urinary magnesium in apparently healthy males. Scand J Clin Lab Invest 55:549–558PubMed Djurhuus MS, Gram J, Petersen PH, Klitgaard NA, Bollerslev J, Beck-Nielsen H (1995) Biological variation of serum and urinary magnesium in apparently healthy males. Scand J Clin Lab Invest 55:549–558PubMed
29.
go back to reference Ryzen E, Elbaum N, Singer FR, Rude RK (1985) Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency. Magnesium 4:137–147PubMed Ryzen E, Elbaum N, Singer FR, Rude RK (1985) Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency. Magnesium 4:137–147PubMed
30.
go back to reference Rob PM, Dick K, Bley N, Seyfert T, Brinckmann C, Hollriegel V, Friedrich HJ, Dibbelt L, Seelig MS (1999) Can one really measure magnesium deficiency using the short-term magnesium loading test? J Intern Med 246:373–378 Rob PM, Dick K, Bley N, Seyfert T, Brinckmann C, Hollriegel V, Friedrich HJ, Dibbelt L, Seelig MS (1999) Can one really measure magnesium deficiency using the short-term magnesium loading test? J Intern Med 246:373–378
31.
go back to reference Koo WWK, Tsang RC (1999) Calcium and magnesium homeostasis. In: Avery GB, Fletcher MA, MacDonald MG (eds) Neonatology—pathophysiology and management of the newborn, vol 1. Lippincott Williams and Wilkins, Philadelphia, p 730 Koo WWK, Tsang RC (1999) Calcium and magnesium homeostasis. In: Avery GB, Fletcher MA, MacDonald MG (eds) Neonatology—pathophysiology and management of the newborn, vol 1. Lippincott Williams and Wilkins, Philadelphia, p 730
32.
go back to reference Cronan K, Norman ME (2000) Renal and electrolyte emergencies. In: Fleisher GR, Ludwig S (eds) Pediatric emergency medicine, vol 1. Lippincott Williams and Wilkins, Philadelphia, p 827 Cronan K, Norman ME (2000) Renal and electrolyte emergencies. In: Fleisher GR, Ludwig S (eds) Pediatric emergency medicine, vol 1. Lippincott Williams and Wilkins, Philadelphia, p 827
33.
go back to reference Gal P, Reed MD (2000) Medications. In: Behrman RE, Kliegman R, Jenson HB (eds) Textbook of pediatrics. Saunders, Philadelphia, p 2270 Gal P, Reed MD (2000) Medications. In: Behrman RE, Kliegman R, Jenson HB (eds) Textbook of pediatrics. Saunders, Philadelphia, p 2270
34.
go back to reference Ranade VV, Somberg JC (2001) Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther 8:345–357PubMed Ranade VV, Somberg JC (2001) Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther 8:345–357PubMed
35.
go back to reference Ryan MP (1986) Magnesium and potassium-sparing diuretics. Magnesium 5:282–292PubMed Ryan MP (1986) Magnesium and potassium-sparing diuretics. Magnesium 5:282–292PubMed
36.
go back to reference Netzer T, Knauf H, Mutschler E (1992) Modulation of electrolyte excretion by potassium retaining diuretics. Eur Heart J 13 [Suppl G]:22–27 Netzer T, Knauf H, Mutschler E (1992) Modulation of electrolyte excretion by potassium retaining diuretics. Eur Heart J 13 [Suppl G]:22–27
37.
go back to reference Colussi G, Rombola G, De Ferrari ME, Macaluso M, Minetti L (1994) Correction of hypokalemia with antialdosterone therapy in Gitelman’s syndrome. Am J Nephrol 14:127–135 Colussi G, Rombola G, De Ferrari ME, Macaluso M, Minetti L (1994) Correction of hypokalemia with antialdosterone therapy in Gitelman’s syndrome. Am J Nephrol 14:127–135
38.
go back to reference Bundy JT, Connito D, Mahoney MD, Pontier PJ (1995) Treatment of idiopathic renal magnesium wasting with amiloride. Am J Nephrol 15:75–77 Bundy JT, Connito D, Mahoney MD, Pontier PJ (1995) Treatment of idiopathic renal magnesium wasting with amiloride. Am J Nephrol 15:75–77
39.
go back to reference Geven WB, Monnens LA, Willems HL, Buijs WC, Haar BG ter (1987) Renal magnesium wasting in two families with autosomal dominant inheritance. Kidney Int 31:1140–1144PubMed Geven WB, Monnens LA, Willems HL, Buijs WC, Haar BG ter (1987) Renal magnesium wasting in two families with autosomal dominant inheritance. Kidney Int 31:1140–1144PubMed
40.
go back to reference Meij I, Illy KE, Monnens L (2000) Severe hypomagnesemia in a neonate with isolated renal magnesium loss. Nephron 84:198CrossRefPubMed Meij I, Illy KE, Monnens L (2000) Severe hypomagnesemia in a neonate with isolated renal magnesium loss. Nephron 84:198CrossRefPubMed
41.
go back to reference Meij IC, Saar K, Heuvel LP van den, Nuernberg G, Vollmer M, Hildebrandt F, Reis A, Monnens LA, Knoers NV (1999) Hereditary isolated renal magnesium loss maps to chromosome 11q23. Am J Hum Genet 64:180–188CrossRefPubMed Meij IC, Saar K, Heuvel LP van den, Nuernberg G, Vollmer M, Hildebrandt F, Reis A, Monnens LA, Knoers NV (1999) Hereditary isolated renal magnesium loss maps to chromosome 11q23. Am J Hum Genet 64:180–188CrossRefPubMed
42.
go back to reference Meij IC, Koenderink JB, Bokhoven H van, Assink KF, Groenestege WT, Pont JJ de, Bindels RJ, Monnens LA, Heuvel LP van den, Knoers NV (2000) Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet 26:265–266PubMed Meij IC, Koenderink JB, Bokhoven H van, Assink KF, Groenestege WT, Pont JJ de, Bindels RJ, Monnens LA, Heuvel LP van den, Knoers NV (2000) Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet 26:265–266PubMed
43.
go back to reference Pu HX, Scanzano R, Blostein R (2002) Distinct regulatory effects of the Na,K-ATPase gamma subunit. J Biol Chem 277:20270–20276CrossRefPubMed Pu HX, Scanzano R, Blostein R (2002) Distinct regulatory effects of the Na,K-ATPase gamma subunit. J Biol Chem 277:20270–20276CrossRefPubMed
44.
go back to reference Kantorovich V, Adams JS, Gaines JE, Guo X, Pandian MR, Cohn DH, Rude RK (2002) Genetic heterogeneity in familial renal magnesium wasting. J Clin Endocrinol Metab 87:612–617PubMed Kantorovich V, Adams JS, Gaines JE, Guo X, Pandian MR, Cohn DH, Rude RK (2002) Genetic heterogeneity in familial renal magnesium wasting. J Clin Endocrinol Metab 87:612–617PubMed
45.
go back to reference Geven WB, Monnens LA, Willems JL, Buijs W, Hamel CJ (1987) Isolated autosomal recessive renal magnesium loss in two sisters. Clin Genet 32:398–402PubMed Geven WB, Monnens LA, Willems JL, Buijs W, Hamel CJ (1987) Isolated autosomal recessive renal magnesium loss in two sisters. Clin Genet 32:398–402PubMed
46.
go back to reference Meij IC, Van Den Heuvel LP, Hemmes S, Van Der Vliet WA, Willems JL, Monnens LA, Knoers NV (2003) Exclusion of mutations in FXYD2, CLDN16 and SLC12A3 in two families with primary renal Mg(2+) loss. Nephrol Dial Transplant 18:512–516CrossRefPubMed Meij IC, Van Den Heuvel LP, Hemmes S, Van Der Vliet WA, Willems JL, Monnens LA, Knoers NV (2003) Exclusion of mutations in FXYD2, CLDN16 and SLC12A3 in two families with primary renal Mg(2+) loss. Nephrol Dial Transplant 18:512–516CrossRefPubMed
47.
go back to reference Michelis MF, Drash AL, Linarelli LG, De Rubertis FR, Davis BB (1972) Decreased bicarbonate threshold and renal magnesium wasting in a sibship with distal renal tubular acidosis. (Evaluation of the pathophysiological role of parathyroid hormone.) Metabolism 21:905–920 Michelis MF, Drash AL, Linarelli LG, De Rubertis FR, Davis BB (1972) Decreased bicarbonate threshold and renal magnesium wasting in a sibship with distal renal tubular acidosis. (Evaluation of the pathophysiological role of parathyroid hormone.) Metabolism 21:905–920
48.
go back to reference Manz F, Scharer K, Janka P, Lombeck J (1978) Renal magnesium wasting, incomplete tubular acidosis, hypercalciuria and nephrocalcinosis in siblings. Eur J Pediatr 128:67–79PubMed Manz F, Scharer K, Janka P, Lombeck J (1978) Renal magnesium wasting, incomplete tubular acidosis, hypercalciuria and nephrocalcinosis in siblings. Eur J Pediatr 128:67–79PubMed
49.
go back to reference Rodriguez-Soriano J, Vallo A, Garcia-Fuentes M (1987) Hypomagnesaemia of hereditary renal origin. Pediatr Nephrol 1:465–472PubMed Rodriguez-Soriano J, Vallo A, Garcia-Fuentes M (1987) Hypomagnesaemia of hereditary renal origin. Pediatr Nephrol 1:465–472PubMed
50.
go back to reference Nicholson JC, Jones CL, Powell HR, Walker RG, McCredie DA (1995) Familial hypomagnesaemia-hypercalciuria leading to end-stage renal failure. Pediatr Nephrol 9:74–76PubMed Nicholson JC, Jones CL, Powell HR, Walker RG, McCredie DA (1995) Familial hypomagnesaemia-hypercalciuria leading to end-stage renal failure. Pediatr Nephrol 9:74–76PubMed
51.
go back to reference Praga M, Vara J, Gonzalez-Parra E, Andres A, Alamo C, Araque A, Ortiz A, Rodicio JL (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47:1419–1425PubMed Praga M, Vara J, Gonzalez-Parra E, Andres A, Alamo C, Araque A, Ortiz A, Rodicio JL (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47:1419–1425PubMed
52.
go back to reference Benigno V, Canonica CS, Bettinelli A, Vigier RO von, Truttmann AC, Bianchetti MG (2000) Hypomagnesaemia-hypercalciuria-nephrocalcinosis: a report of nine cases and a review. Nephrol Dial Transplant 15:605–610PubMed Benigno V, Canonica CS, Bettinelli A, Vigier RO von, Truttmann AC, Bianchetti MG (2000) Hypomagnesaemia-hypercalciuria-nephrocalcinosis: a report of nine cases and a review. Nephrol Dial Transplant 15:605–610PubMed
53.
go back to reference Weber S, Schneider L, Peters M, Misselwitz J, Ronnefarth G, Boswald M, Bonzel KE, Seeman T, Sulakova T, Kuwertz-Broking E, Gregoric A, Palcoux JB, Tasic V, Manz F, Scharer K, Seyberth HW, Konrad M (2001) Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 12:1872–1881PubMed Weber S, Schneider L, Peters M, Misselwitz J, Ronnefarth G, Boswald M, Bonzel KE, Seeman T, Sulakova T, Kuwertz-Broking E, Gregoric A, Palcoux JB, Tasic V, Manz F, Scharer K, Seyberth HW, Konrad M (2001) Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 12:1872–1881PubMed
54.
go back to reference Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285:103–106PubMed Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285:103–106PubMed
55.
go back to reference Wong V, Goodenough DA (1999) Paracellular channels! Science 285:62 Wong V, Goodenough DA (1999) Paracellular channels! Science 285:62
56.
go back to reference Meij IC, Heuvel LP van den, Knoers NV (2002) Genetic disorders of magnesium homeostasis. Biometals 15:297–307CrossRefPubMed Meij IC, Heuvel LP van den, Knoers NV (2002) Genetic disorders of magnesium homeostasis. Biometals 15:297–307CrossRefPubMed
57.
go back to reference Blanchard A, Jeunemaitre X, Coudol P, Dechaux M, Froissart M, May A, Demontis R, Fournier A, Paillard M, Houillier P (2001) Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 59:2206–2215PubMed Blanchard A, Jeunemaitre X, Coudol P, Dechaux M, Froissart M, May A, Demontis R, Fournier A, Paillard M, Houillier P (2001) Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 59:2206–2215PubMed
58.
go back to reference Müller D, Claverie-Martin F, Eggert P, Garcia-Nieto V (2002) Mutationen im PDZ-Motif von Paracellin-1 als Ursache der Hyperkalziurie im Kindesalter (abstract). Nieren Hochdruckkrankheiten 31:52 Müller D, Claverie-Martin F, Eggert P, Garcia-Nieto V (2002) Mutationen im PDZ-Motif von Paracellin-1 als Ursache der Hyperkalziurie im Kindesalter (abstract). Nieren Hochdruckkrankheiten 31:52
59.
go back to reference Paunier L, Radde IC, Kooh SW, Conen PE, Fraser D (1968) Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics 41:385–402PubMed Paunier L, Radde IC, Kooh SW, Conen PE, Fraser D (1968) Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics 41:385–402PubMed
60.
go back to reference Anast CS, Mohs JM, Kaplan SL, Burns TW (1972) Evidence for parathyroid failure in magnesium deficiency. Science 177:606–608PubMed Anast CS, Mohs JM, Kaplan SL, Burns TW (1972) Evidence for parathyroid failure in magnesium deficiency. Science 177:606–608PubMed
61.
go back to reference Michelis MF, Bragdon RW, Fusco RD, Eichenholz A, Davis BB (1975) Parathyroid hormone responsiveness in hypoparathyroidism with hypomagnesemia. Am J Med Sci 270:412–418PubMed Michelis MF, Bragdon RW, Fusco RD, Eichenholz A, Davis BB (1975) Parathyroid hormone responsiveness in hypoparathyroidism with hypomagnesemia. Am J Med Sci 270:412–418PubMed
62.
go back to reference Rude RK, Oldham SB, Singer FR (1976) Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 5:209–224 Rude RK, Oldham SB, Singer FR (1976) Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 5:209–224
63.
go back to reference Freitag JJ, Martin KJ, Conrades MB, Bellorin-Font E, Teitelbaum S, Klahr S, Slatopolsky E (1979) Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone. J Clin Invest 64:1238–1244PubMed Freitag JJ, Martin KJ, Conrades MB, Bellorin-Font E, Teitelbaum S, Klahr S, Slatopolsky E (1979) Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone. J Clin Invest 64:1238–1244PubMed
64.
go back to reference Cole DE, Kooh SW, Vieth R (2000) Primary infantile hypomagnesaemia: outcome after 21 years and treatment with continuous nocturnal nasogastric magnesium infusion. Eur J Pediatr 159:38–43CrossRefPubMed Cole DE, Kooh SW, Vieth R (2000) Primary infantile hypomagnesaemia: outcome after 21 years and treatment with continuous nocturnal nasogastric magnesium infusion. Eur J Pediatr 159:38–43CrossRefPubMed
65.
go back to reference Shalev H, Phillip M, Galil A, Carmi R, Landau D (1998) Clinical presentation and outcome in primary familial hypomagnesaemia. Arch Dis Child 78:127–130PubMed Shalev H, Phillip M, Galil A, Carmi R, Landau D (1998) Clinical presentation and outcome in primary familial hypomagnesaemia. Arch Dis Child 78:127–130PubMed
66.
go back to reference Aries PM, Schubert M, Muller-Wieland D, Krone W (2000) Subcutaneous magnesium pump in a patient with combined magnesium transport defect. Dtsch Med Wochenschr 125:970–972CrossRefPubMed Aries PM, Schubert M, Muller-Wieland D, Krone W (2000) Subcutaneous magnesium pump in a patient with combined magnesium transport defect. Dtsch Med Wochenschr 125:970–972CrossRefPubMed
67.
go back to reference Milla PJ, Aggett PJ, Wolff OH, Harries JT (1979) Studies in primary hypomagnesaemia: evidence for defective carrier-mediated small intestinal transport of magnesium. Gut 20:1028–1033PubMed Milla PJ, Aggett PJ, Wolff OH, Harries JT (1979) Studies in primary hypomagnesaemia: evidence for defective carrier-mediated small intestinal transport of magnesium. Gut 20:1028–1033PubMed
68.
go back to reference Matzkin H, Lotan D, Boichis H (1989) Primary hypomagnesemia with a probable double magnesium transport defect. Nephron 52:83–86PubMed Matzkin H, Lotan D, Boichis H (1989) Primary hypomagnesemia with a probable double magnesium transport defect. Nephron 52:83–86PubMed
69.
go back to reference Walder RY, Shalev H, Brennan TM, Carmi R, Elbedour K, Scott DA, Hanauer A, Mark AL, Patil S, Stone EM, Sheffield VC (1997) Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of a balanced translocation breakpoint. Hum Mol Genet 6:1491–1497CrossRefPubMed Walder RY, Shalev H, Brennan TM, Carmi R, Elbedour K, Scott DA, Hanauer A, Mark AL, Patil S, Stone EM, Sheffield VC (1997) Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of a balanced translocation breakpoint. Hum Mol Genet 6:1491–1497CrossRefPubMed
70.
go back to reference Walder RY, Borochowitz Z, Shalev H, Carmi R, Elbedour K, Scott DA, Stone EM, Sheffield VC (1999) Hypomagnesemia with secondary hypocalcemia (HSH): narrowing the disease region on chromosome 9 (abstract). Am J Hum Genet 65:A451 Walder RY, Borochowitz Z, Shalev H, Carmi R, Elbedour K, Scott DA, Stone EM, Sheffield VC (1999) Hypomagnesemia with secondary hypocalcemia (HSH): narrowing the disease region on chromosome 9 (abstract). Am J Hum Genet 65:A451
71.
go back to reference Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M (2002) Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31:166–170CrossRefPubMed Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M (2002) Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31:166–170CrossRefPubMed
72.
go back to reference Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, Sheffield VC (2002) Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 31:171–174CrossRefPubMed Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, Sheffield VC (2002) Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 31:171–174CrossRefPubMed
73.
go back to reference Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, Fleig A (2001) LTRPC7 is a Mg-ATP-regulated divalent cation channel required for cell viability. Nature 411:590–595CrossRefPubMed Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, Fleig A (2001) LTRPC7 is a Mg-ATP-regulated divalent cation channel required for cell viability. Nature 411:590–595CrossRefPubMed
74.
go back to reference Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC (1993) Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366:575–580PubMed Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC (1993) Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366:575–580PubMed
75.
go back to reference Bapty BW, Dai LJ, Ritchie G, Canaff L, Hendy GN, Quamme GA (1998) Activation of Mg2+/Ca2+ sensing inhibits hormone-stimulated Mg2+ uptake in mouse distal convoluted tubule cells. Am J Physiol 275:F353–F360PubMed Bapty BW, Dai LJ, Ritchie G, Canaff L, Hendy GN, Quamme GA (1998) Activation of Mg2+/Ca2+ sensing inhibits hormone-stimulated Mg2+ uptake in mouse distal convoluted tubule cells. Am J Physiol 275:F353–F360PubMed
76.
go back to reference Hebert SC (1996) Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int 50:2129–2139PubMed Hebert SC (1996) Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int 50:2129–2139PubMed
77.
go back to reference Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239–297PubMed Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239–297PubMed
78.
go back to reference Wang W, Lu M, Balazy M, Hebert SC (1997) Phospholipase A2 is involved in mediating the effect of extracellular Ca2+ on apical K+ channels in rat TAL. Am J Physiol 273:F421–F429PubMed Wang W, Lu M, Balazy M, Hebert SC (1997) Phospholipase A2 is involved in mediating the effect of extracellular Ca2+ on apical K+ channels in rat TAL. Am J Physiol 273:F421–F429PubMed
79.
go back to reference Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG (1993) Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297–1303PubMed Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG (1993) Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297–1303PubMed
80.
go back to reference Pollak MR, Chou YH, Marx SJ, Steinmann B, Cole DE, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE, Seidman JG (1994) Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93:1108–1112PubMed Pollak MR, Chou YH, Marx SJ, Steinmann B, Cole DE, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE, Seidman JG (1994) Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93:1108–1112PubMed
81.
go back to reference Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW Jr, Lasker RD (1981) The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 60:397–412 Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW Jr, Lasker RD (1981) The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 60:397–412
82.
go back to reference Cole DE, Janicic N, Salisbury SR, Hendy GN (1997) Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. Am J Med Genet 71:202–210CrossRefPubMed Cole DE, Janicic N, Salisbury SR, Hendy GN (1997) Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. Am J Med Genet 71:202–210CrossRefPubMed
83.
go back to reference Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, Park J, Hebert SC, Seidman CE, Seidman JG (1994) Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation. Nat Genet 8:303–307PubMed Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, Park J, Hebert SC, Seidman CE, Seidman JG (1994) Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation. Nat Genet 8:303–307PubMed
84.
go back to reference Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV (1996) A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335:1115–1122PubMed Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV (1996) A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335:1115–1122PubMed
85.
go back to reference Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T (2002) Association between activating mutations of calcium-sensing receptor and Bartter’s syndrome. Lancet 360:692–694CrossRefPubMed Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T (2002) Association between activating mutations of calcium-sensing receptor and Bartter’s syndrome. Lancet 360:692–694CrossRefPubMed
86.
go back to reference Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaitre X, Paillard M, Planelles G, Dechaux M, Miller RT, Antignac C (2002) Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 13:2259–2266 Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaitre X, Paillard M, Planelles G, Dechaux M, Miller RT, Antignac C (2002) Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 13:2259–2266
87.
go back to reference Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP (1996) Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13:183–188PubMed Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP (1996) Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13:183–188PubMed
88.
go back to reference Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, Sanjad SA, Lifton RP (1996) Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14:152–156PubMed Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, Sanjad SA, Lifton RP (1996) Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14:152–156PubMed
89.
go back to reference International Collaborative Study Group for Bartter-like Syndromes (1997) Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. International Collaborative Study Group for Bartter-like Syndromes. Hum Mol Genet 6:17–26CrossRefPubMed International Collaborative Study Group for Bartter-like Syndromes (1997) Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. International Collaborative Study Group for Bartter-like Syndromes. Hum Mol Genet 6:17–26CrossRefPubMed
90.
go back to reference Greger R (1985) Ion transport mechanisms in thick ascending limb of Henle’s loop of mammalian nephron. Physiol Rev 65:760–797PubMed Greger R (1985) Ion transport mechanisms in thick ascending limb of Henle’s loop of mammalian nephron. Physiol Rev 65:760–797PubMed
91.
go back to reference Seyberth H, Soergel M, Koeckerling A (1998) Hypokalaemic tubular disorders: the hyperprostaglandin E syndrome and Gitelman-Bartter syndrome. In: Davison A, Cameron J, Grünfeld J, Kerr D, Ritz E, Winearls C (eds) Oxford textbook of clinical nephrology. Oxford University Press, Oxford, pp 1085–1093 Seyberth H, Soergel M, Koeckerling A (1998) Hypokalaemic tubular disorders: the hyperprostaglandin E syndrome and Gitelman-Bartter syndrome. In: Davison A, Cameron J, Grünfeld J, Kerr D, Ritz E, Winearls C (eds) Oxford textbook of clinical nephrology. Oxford University Press, Oxford, pp 1085–1093
92.
go back to reference Dai LJ, Bapty B, Ritchie G, Quamme GA (1998) PGE2 stimulates Mg2+ uptake in mouse distal convoluted tubule cells. Am J Physiol 275:F833–F839PubMed Dai LJ, Bapty B, Ritchie G, Quamme GA (1998) PGE2 stimulates Mg2+ uptake in mouse distal convoluted tubule cells. Am J Physiol 275:F833–F839PubMed
93.
go back to reference Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J, Morales JM, Sanjad SA, Taylor CM, Pilz D, Brem A, Trachtman H, Griswold W, Richard GA, John E, Lifton RP (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III. Nat Genet 17:171–178PubMed Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J, Morales JM, Sanjad SA, Taylor CM, Pilz D, Brem A, Trachtman H, Griswold W, Richard GA, John E, Lifton RP (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III. Nat Genet 17:171–178PubMed
94.
go back to reference Konrad M, Vollmer M, Lemmink HH, Van Den Heuvel LP, Jeck N, Vargas-Poussou R, Lakings A, Ruf R, Deschenes G, Antignac C, Guay-Woodford L, Knoers NV, Seyberth HW, Feldmann D, Hildebrandt F (2000) Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 11:1449–1459 Konrad M, Vollmer M, Lemmink HH, Van Den Heuvel LP, Jeck N, Vargas-Poussou R, Lakings A, Ruf R, Deschenes G, Antignac C, Guay-Woodford L, Knoers NV, Seyberth HW, Feldmann D, Hildebrandt F (2000) Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 11:1449–1459
95.
go back to reference Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HW (2000) Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res 48:754–758PubMed Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HW (2000) Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res 48:754–758PubMed
96.
go back to reference Peters M, Jeck N, Reinalter S, Leonhardt A, Tönshoff B, Klaus GG, Konrad M, Seyberth HW (2002) Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 112:183–190CrossRefPubMed Peters M, Jeck N, Reinalter S, Leonhardt A, Tönshoff B, Klaus GG, Konrad M, Seyberth HW (2002) Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 112:183–190CrossRefPubMed
97.
go back to reference Zelikovic I, Szargel R, Hawash A, Labay V, Hatib I, Cohen N, Nakhoul F (2003) A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 63:24–32CrossRefPubMed Zelikovic I, Szargel R, Hawash A, Labay V, Hatib I, Cohen N, Nakhoul F (2003) A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 63:24–32CrossRefPubMed
98.
go back to reference Bartter F, Pronove P, Gill J Jr, MacCardle R (1962) Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 33:811–828 Bartter F, Pronove P, Gill J Jr, MacCardle R (1962) Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 33:811–828
99.
go back to reference Birkenhager R, Otto E, Schurmann MJ, Vollmer M, Ruf EM, Maier-Lutz I, Beekmann F, Fekete A, Omran H, Feldmann D, Milford DV, Jeck N, Konrad M, Landau D, Knoers NV, Antignac C, Sudbrak R, Kispert A, Hildebrandt F (2001) Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29:310–314CrossRefPubMed Birkenhager R, Otto E, Schurmann MJ, Vollmer M, Ruf EM, Maier-Lutz I, Beekmann F, Fekete A, Omran H, Feldmann D, Milford DV, Jeck N, Konrad M, Landau D, Knoers NV, Antignac C, Sudbrak R, Kispert A, Hildebrandt F (2001) Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29:310–314CrossRefPubMed
100.
go back to reference Estevez R, Boettger T, Stein V, Birkenhager R, Otto E, Hildebrandt F, Jentsch TJ (2001) Barttin is a Cl− channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion. Nature 414:558–561CrossRefPubMed Estevez R, Boettger T, Stein V, Birkenhager R, Otto E, Hildebrandt F, Jentsch TJ (2001) Barttin is a Cl channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion. Nature 414:558–561CrossRefPubMed
101.
go back to reference Waldegger S, Jeck N, Barth P, Peters M, Vitzthum H, Wolf K, Kurtz A, Konrad M, Seyberth HW (2002) Barttin increases surface expression and changes current properties of ClC-K channels. Pflugers Arch 444:411–418CrossRefPubMed Waldegger S, Jeck N, Barth P, Peters M, Vitzthum H, Wolf K, Kurtz A, Konrad M, Seyberth HW (2002) Barttin increases surface expression and changes current properties of ClC-K channels. Pflugers Arch 444:411–418CrossRefPubMed
102.
go back to reference Landau D, Shalev H, Ohaly M, Carmi R (1995) Infantile variant of Bartter syndrome and sensorineural deafness: a new autosomal recessive disorder. Am J Med Genet 59:454–459PubMed Landau D, Shalev H, Ohaly M, Carmi R (1995) Infantile variant of Bartter syndrome and sensorineural deafness: a new autosomal recessive disorder. Am J Med Genet 59:454–459PubMed
103.
go back to reference Jeck N, Reinalter SC, Henne T, Marg W, Mallmann R, Pasel K, Vollmer M, Klaus G, Leonhardt A, Seyberth HW, Konrad M (2001) Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics 108:E5PubMed Jeck N, Reinalter SC, Henne T, Marg W, Mallmann R, Pasel K, Vollmer M, Klaus G, Leonhardt A, Seyberth HW, Konrad M (2001) Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics 108:E5PubMed
104.
go back to reference Gitelman HJ, Graham JB, Welt LG (1966) A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 79:221–235PubMed Gitelman HJ, Graham JB, Welt LG (1966) A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 79:221–235PubMed
105.
go back to reference Bettinelli A, Bianchetti MG, Girardin E, Caringella A, Cecconi M, Appiani AC, Pavanello L, Gastaldi R, Isimbaldi C, Lama G, et al (1992) Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 120:38–43PubMed Bettinelli A, Bianchetti MG, Girardin E, Caringella A, Cecconi M, Appiani AC, Pavanello L, Gastaldi R, Isimbaldi C, Lama G, et al (1992) Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 120:38–43PubMed
106.
go back to reference Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB (2001) Gitelman’s syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 59:710–717PubMed Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB (2001) Gitelman’s syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 59:710–717PubMed
107.
go back to reference Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitelman HJ, Lifton RP (1996) Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12:24–30PubMed Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitelman HJ, Lifton RP (1996) Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12:24–30PubMed
108.
go back to reference Yang T, Huang YG, Singh I, Schnermann J, Briggs JP (1996) Localization of bumetanide- and thiazide-sensitive Na-K-Cl cotransporters along the rat nephron. Am J Physiol 271:F931–F939PubMed Yang T, Huang YG, Singh I, Schnermann J, Briggs JP (1996) Localization of bumetanide- and thiazide-sensitive Na-K-Cl cotransporters along the rat nephron. Am J Physiol 271:F931–F939PubMed
109.
go back to reference Reilly RF, Ellison DH (2000) Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol Rev 80:277–313PubMed Reilly RF, Ellison DH (2000) Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol Rev 80:277–313PubMed
110.
go back to reference Kiuchi-Saishin Y, Gotoh S, Furuse M, Takasuga A, Tano Y, Tsukita S (2002) Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 13:875–886 Kiuchi-Saishin Y, Gotoh S, Furuse M, Takasuga A, Tano Y, Tsukita S (2002) Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 13:875–886
111.
go back to reference Loffing J, Loffing-Cueni D, Hegyi I, Kaplan MR, Hebert SC, Le Hir M, Kaissling B (1996) Thiazide treatment of rats provokes apoptosis in distal tubule cells. Kidney Int 50:1180–1190PubMed Loffing J, Loffing-Cueni D, Hegyi I, Kaplan MR, Hebert SC, Le Hir M, Kaissling B (1996) Thiazide treatment of rats provokes apoptosis in distal tubule cells. Kidney Int 50:1180–1190PubMed
112.
go back to reference Schultheis PJ, Lorenz JN, Meneton P, Nieman ML, Riddle TM, Flagella M, Duffy JJ, Doetschman T, Miller ML, Shull GE (1998) Phenotype resembling Gitelman’s syndrome in mice lacking the apical Na+-Cl- cotransporter of the distal convoluted tubule. J Biol Chem 273:29150–29155PubMed Schultheis PJ, Lorenz JN, Meneton P, Nieman ML, Riddle TM, Flagella M, Duffy JJ, Doetschman T, Miller ML, Shull GE (1998) Phenotype resembling Gitelman’s syndrome in mice lacking the apical Na+-Cl- cotransporter of the distal convoluted tubule. J Biol Chem 273:29150–29155PubMed
Metadata
Title
Genetics of hereditary disorders of magnesium homeostasis
Authors
Karl P. Schlingmann
Martin Konrad
Hannsjörg W. Seyberth
Publication date
01-01-2004
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 1/2004
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-003-1293-z

Other articles of this Issue 1/2004

Pediatric Nephrology 1/2004 Go to the issue